Trends In Compulsory Licensing Of Pharmaceuticals Since Doha Declaration

In this PLoS Medicine research article, Reed Beall and Randall Kuhn of the Josef Korbel School of International Studies at the University of Denver provide an analysis of trends in compulsory licensing (CL) of pharmaceuticals since the Doha Declaration. “Almost 10 years after the Doha Declaration, we examined the subsequent occurrence of CL episodes, an important direct indicator of treaty impact,” they write. Given that “compulsory licensing activity has diminished greatly since 2006, … the researchers conclude, health advocates who pushed for the Doha Declaration reforms have had little success in engaging trade as a positive, proactive force for addressing health gaps,” according to the article’s Editors’ Summary (1/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.